NAG (ASX) The ones that got away

Originally posted by muzzab ↑

This is a great article that I think all stock market investors, particularly those who invest in speculative stocks like NAG, would take heart from. It comes from Margus Padley at http://marcustoday.com.au/webpages/832_education.php?guid=5febee425ba37bbae6090475fd1baecf&id=30598

THE ONES THAT GOT AWAY

"In 2003 I held 250,000 Oil Search at 60c. Sold them at 70c, they later hit $9.83. That’s $2.5m missed.

I also once held 50,000 Zinifex at 200c (it turned into Oz Minerals). Sold them at 240c. They hit $21.60. That’s another million.

In 2003 I held 250,000 Oil Search at 60c. Sold them at 70c, they later hit $9.83. That’s $2.5m missed.

I also once held 50,000 Zinifex at 200c. Sold them at 240c. They hit $21.60. That’s another million.

Then there was the tech boom. That involved selling 200,000 Davnet at 40c, they went to $6, and selling 300,000 Voicenet at 38c that later hit $3.80. Add them up and that’s another $2.35m missed.

These are just some of the ones that got away from me. No doubt you have your own story.

But the most tortuous element of all the above trades, trades that got sold through my impatience, is that all I had to do to make 5.85 million dollars was to do absolutely nothing at all., trades that got sold through my impatience, is that all I had to do to make $5.85 million was to do absolutely nothing at all. Instead I fiddled my way out of it. An activity that any commission driven broker is paid to do, creating activity for activity’s sake, for a commission, when the best course of action was to simply invest, not tinker.

But forget the $5.85 million, my best stock market opportunity came when I was working at Barton Capital and we got a visit from the investor relations guy of some crappy resources stock. It was February 2004. He was a friend, used to work with him at ABN AMRO, so when he asked if he could come in and sell his wares to the broking desk I made an exception and said “Yes”.

Days later the traders were all over it, the volume was rising, the price had ripped up from 1.2c to 3.3c and on momentum alone I had personally bought a million shares at 1.6c. Within a month they were 2.6c. Now I’m no fool and as any stock broker will tell you, when you find yourself standing at the desk punching the air in delight it can only mean one thing, “Sell!” So I did. It was a holiday in Bali for goodness sake.

Now what was that crappy little resources stock called again? Oh yes. That was it. Paladin. I once held a million Paladin at 1.6c. They went to $10.80. That’s another $10.8 million left on the table.

There used to be a bit of a stock broker thing that you needed "X" to retire, but it had to be a lot. Win a million on Tatts Lotto and it doesn’t actually change things. You need more. A million isn’t a million to a retiree, it represents around $50,000 a year of risk free income, so you need more. So we settled on an X of $5m, a number at which we would throw the job in immediately and plan the rest of our lives.

Paladin would have delivered twice as much.

Of course I sold almost all these trades because I had something else to do with the money, because 'fiddling' was my job. But with Paladin I had only risked $16,000, I didn’t need that $16,000, and not needing it is the most essential element of long term patient investment. And all I had had to do was absolutely nothing.

They say it’s better to regret the things you’ve done rather than the things you haven’t and I assume they’re right. You only get one shot. To have had your chance at transformation, even if you didn’t know it, is a thrilling part of ‘playing’ the stock market, realising that you were once in the box seat is an everlasting reminder that at any moment you could be again, and what better challenge could there be than knowing that right now, at this very moment, in the pages of the internet, perhaps even in the pages of Marcus Today, the next Paladin is right in front of you, if only you could see it.

So whilst a compliance hamstrung advice industry is forced to deliver a monotone sermon about average returns, diversification, spreading risk, safe income, portfolio optimization, capital protection, asset allocation, expected returns, efficient markets, rational markets, normal distributions, variance, standard deviation, correlated asset classes and all that other mother jazz, let’s spare a moment for that little bit in all of us, in the advisers as well, that doesn’t want a normal distribution, that doesn’t want the average, that doesn’t want expected returns and that doesn’t want one standard deviation from the norm.

All of us, whether we are allowed to express it or not are always in the stock market in the hope that today could be the day we snag the stock that will return the most unexpected, abnormal, massive return, a return that will make a difference to the rest of our lives.

What we all quietly want is the next Paladin, the transformation, the glory of what is possible, and barring the luck of the casino, the lottery, being born rich or marrying rich, outside of building our own business the stock market is the one place that it is on offer to the intellectual. It is, and remains, the most fascinating financial pursuit of all, and let’s face it, if the last organ to pack it in is the brain, most of us will be doing it long after the other fires have burnt out."

Expand

Yes if only we had kept some of the ones we had.

I had SMM at 17c, sold it at $2 and then PDN took it over basically for $6.50 if i remember correctly, that was one of my better ones.
I missed Zinifex but had Oxiana. You brought back some memories.

However i totally agree with you and have had plenty that i sold and they just kept going, I have actually adjusted my trading/investing because of this problem. One current example is 88e, i bought at 1.3c, sold three quarters of them at about 7c+ a year or so ago and still hold the remaining 25% but don't touch them. I still trade the share as per normal though. I find that doing it this way makes it easier psycologically for me to handle the ups and downs when holding for the long term because its profit invested rather than ones capital.

Best Wishes

No.	Vol.	Price($)
2	17589	1.9¢

No.

Vol.

Price($)

17589

1.9¢

Price($)	Vol.	No.
2.0¢	188489	2

Price($)

Vol.

No.

2.0¢

188489

No.	Vol.	Price($)
1	475	0.019
1	20000	0.018
1	600000	0.017
2	249562	0.016
3	599999	0.015

No.

Vol.

Price($)

475

0.019

20000

0.018

600000

0.017

249562

0.016

599999

0.015

Price($)	Vol.	No.
0.020	188489	2
0.021	100000	1
0.022	245055	1
0.025	100000	1
0.026	526000	2

Price($)

Vol.

No.

0.020

188489

0.021

100000

0.022

245055

0.025

100000

0.026

526000

(20min delay)
Last 1.9¢		Change -0.002(9.52%)		Mkt cap ! $15.13M

Open	High	Low	Value	Volume
2.0¢	2.0¢	1.9¢	$8.171K	420.5K

Yes if only we had kept some of the ones we had. :rolleyes: I...

As Nvidia cools, we're looking to Aussie AI

Shekel Brainweigh investor presentation webinar – the future of retail automation

Red Mountain Mining: record gold prices, two projects, two greenstone belts

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes if only we had kept some of the ones we had. :rolleyes: I...

Top Stories

As Nvidia cools, we're looking to Aussie AI

Shekel Brainweigh investor presentation webinar – the future of retail automation

Red Mountain Mining: record gold prices, two projects, two greenstone belts

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News